Skip to main content

Cannabis use is associated with patient and clinical factors in a population-based sample of colorectal cancer survivors

A Correction to this article was published on 19 October 2021

This article has been updated

Abstract

Purpose

This study aimed to characterize patient and clinical factors associated with cannabis (marijuana) use among patients diagnosed with colorectal cancer (CRC).

Methods

We identified CRC patients, diagnosed from 2016 to 2018, using the Seattle-Puget Sound Surveillance, Epidemiology, and End Results (SEER) cancer registry. CRC patients were recruited via mail and telephone, and participants completed a questionnaire eliciting information on medical history, demographics, and lifestyle factors, including cannabis use. Cancer stage was obtained from SEER registry data.

Results

Of 1,433 survey respondents, 339 (24%) were current cannabis users. Current cannabis use was associated with younger age at diagnosis, lower BMI, and a higher prevalence of cigarette smoking and alcohol consumption (p-value < 0.05). Cannabis use was also associated with lower quality of life scores (FACT-C) and advanced-stage cancer (p-value < 0.05).

Conclusion

Cannabis use among CRC patients was common. Patients with more advanced disease were more likely to report cannabis use. Use also varied by some personal factors, consistent with patterns in the general population. Given the high prevalence of cannabis use among CRC patients, research is needed to determine the benefits and harms of cannabis use for symptom management in cancer patients.

This is a preview of subscription content, access via your institution.

Change history

References

  1. Legislatures NCoS (2019) State Medical Marijuana Laws. National Conference of State Legislatures. Available at https://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx

  2. Compton WM, Han B, Hughes A, Jones CM, Blanco C (2017) Use of marijuana for medical purposes among adults in the United States. Jama-J Am Med Assoc 317(2):209–211. https://doi.org/10.1001/jama.2016.18900

    Article  Google Scholar 

  3. Pergolizzi JV Jr, Taylor R, LeQuang JA, Zampogna G, Raffa RB (2017) Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting. Cancer Chemother Pharmacol 79(3):467–477. https://doi.org/10.1007/s00280-017-3257-1

    CAS  Article  PubMed  Google Scholar 

  4. Rabgay K, Waranuch N, Chaiyakunapruk N, Sawangjit R, Ingkaninan K, Dilokthornsakul P (2019) The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: a systematic review and network meta-analysis. J Am Pharm Assoc. https://doi.org/10.1016/j.japh.2019.07.015

    Article  Google Scholar 

  5. Ilgen MA, Bohnert K, Kleinberg F, Jannausch M, Bohnert AS, Walton M, Blow FC (2013) Characteristics of adults seeking medical marijuana certification. Drug Alcohol Depend 132(3):654–659. https://doi.org/10.1016/j.drugalcdep.2013.04.019

    Article  PubMed  Google Scholar 

  6. Pergam SA, Woodfield MC, Lee CM, Cheng GS, Baker KK, Marquis SR, Fann JR (2017) Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use. Cancer 123(22):4488–4497. https://doi.org/10.1002/cncr.30879

    CAS  Article  PubMed  Google Scholar 

  7. Calcaterra SL, Burnett-Hartman AN, Powers JD, Corley DA, McMullen CM, Pawloski PA, Feigelson HS (2020) A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors. BMC Cancer 20(1):373. https://doi.org/10.1186/s12885-020-06887-1

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. Siegel RL, Miller KD, Jemal A (2020) Cancer statistics. Cancer J Clin 70(1):7–30. https://doi.org/10.3322/caac.21590

    Article  Google Scholar 

  9. Ecker AH, Lang B, Hogan J, Cucciare MA, Lindsay J (2020) Cannabis use disorder among veterans: comorbidity and mental health treatment utilization. J Subst Abuse Treat 109:46–49. https://doi.org/10.1016/j.jsat.2019.11.003

    Article  PubMed  Google Scholar 

  10. Shen JJ, Shan G, Kim PC, Yoo JW, Dodge-Francis C, Lee YJ (2019) Trends and related factors of cannabis-associated emergency department visits in the United States: 2006–2014. J Addict Med 13(3):193–200. https://doi.org/10.1097/adm.0000000000000479

    Article  PubMed  Google Scholar 

  11. Park HS, Lloyd S, Decker RH, Wilson LD, Yu JB (2012) Overview of the surveillance, epidemiology, and end results database: evolution, data variables, and quality assurance. Curr Probl Cancer 36(4):183–190. https://doi.org/10.1016/j.currproblcancer.2012.03.007

    Article  PubMed  Google Scholar 

  12. Enewold L, Parsons H, Zhao L, Bott D, Rivera DR, Barrett MJ, Virnig BA, Warren JL (2020) Updated overview of the SEER-medicare data: enhanced content and applications. JNCI Monogr 55:3–13. https://doi.org/10.1093/jncimonographs/lgz029

    Article  Google Scholar 

  13. Seiffert JE (1997) Development and use of the North American Association of Central Cancer Registries standards for cancer registries. Top Health Inf Manag 17(3):35–44

    CAS  Google Scholar 

  14. Ward WL, Hahn EA, Mo F, Hernandez L, Tulsky DS, Cella D (1999) Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res 8(3):181–195

    CAS  Article  PubMed  Google Scholar 

  15. Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, Hall D, Hopper JL, Jass J, Le Marchand L, Limburg P, Lindor N, Potter JD, Templeton AS, Thibodeau S, Seminara D (2007) Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 16(11):2331–2343. https://doi.org/10.1158/1055-9965.Epi-07-0648

    Article  PubMed  Google Scholar 

  16. Tetrault JM, Crothers K, Moore BA, Mehra R, Concato J, Fiellin DA (2007) Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med 167(3):221–228. https://doi.org/10.1001/archinte.167.3.221

    Article  PubMed  PubMed Central  Google Scholar 

  17. Aldington S, Harwood M, Cox B, Weatherall M, Beckert L, Hansell A, Pritchard A, Robinson G, Beasley R, Cannabis, Respiratory Disease Research G (2008) Cannabis use and risk of lung cancer: a case–control study. Eur Respir J 31(2):280–286. https://doi.org/10.1183/09031936.00065707

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  18. Compton WM, Han B, Jones CM, Blanco C, Hughes A (2016) Marijuana use and use disorders in adults in the USA, 2002–14: analysis of annual cross-sectional surveys. Lancet Psychiatry 3(10):954–964. https://doi.org/10.1016/S2215-0366(16)30208-5

    Article  PubMed  Google Scholar 

  19. Schauer GL, Njai R, Grant-Lenzy AM (2020) Modes of marijuana use—smoking, vaping, eating, and dabbing: results from the 2016 BRFSS in 12 States. Drug Alcohol Depen 209:107900. https://doi.org/10.1016/j.drugalcdep.2020.107900

    Article  Google Scholar 

  20. Dai H, Richter KP (2019) A national survey of marijuana use among US adults with medical conditions, 2016–2017. JAMA Netw Open 2(9):e1911936

    Article  PubMed  PubMed Central  Google Scholar 

  21. Cleeland CS, Zhao F, Chang VT, Sloan JA, O’Mara AM, Gilman PB, Weiss M, Mendoza TR, Lee JW, Fisch MJ (2013) The symptom burden of cancer: evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer 119(24):4333–4340. https://doi.org/10.1002/cncr.28376

    Article  PubMed  Google Scholar 

  22. Averyt JC, Nishimoto PW (2014) Psychosocial issues in colorectal cancer survivorship: the top ten questions patients may not be asking. J Gastrointest Oncol 5(5):395–400. https://doi.org/10.3978/j.issn.2078-6891.2014.058

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ramsey SD, Berry K, Moinpour C, Giedzinska A, Andersen MR (2002) Quality of life in long term survivors of colorectal cancer. Am J Gastroenterol 97(5):1228–1234

    Article  PubMed  Google Scholar 

  24. Abrams DI (2016) Integrating cannabis into clinical cancer care. Curr Oncol (Toronto, Ont) 23(2):S8–S14. https://doi.org/10.3747/co.23.3099

    CAS  Article  Google Scholar 

  25. Dorn HF, Cutler SJ (1955) Morbidity from cancer in the United States. I. Variation in incidence by age, sex, race, marital status, and geographic region. Public Health Monogr 29:1–121

    CAS  PubMed  Google Scholar 

  26. Manton KG, Akushevich I, Kravchenko J (2008) Cancer mortality and morbidity patterns in the U.S. population. Springer, New York

    Google Scholar 

  27. El-Shami K, Oeffinger KC, Erb NL, Willis A, Bretsch JK, Pratt-Chapman ML, Cannady RS, Wong SL, Rose J, Barbour AL, Stein KD, Sharpe KB, Brooks DD, Cowens-Alvarado RL (2015) American cancer society colorectal cancer survivorship care guidelines. CA Cancer J Clin 65(6):427–455. https://doi.org/10.3322/caac.21286

    Article  Google Scholar 

  28. Moore AR, Buchanan ND, Fairley TL, Lee Smith J (2015) Public health action model for cancer survivorship. Am J Prev Med 49(6 Suppl 5):S470–S476. https://doi.org/10.1016/j.amepre.2015.09.001S0749-3797(15)00521-8[pii]

    Article  PubMed  PubMed Central  Google Scholar 

  29. Azofeifa A, Mattson ME, Schauer G, McAfee T, Grant A, Lyerla R (2016) National estimates of marijuana use and related indicators—national survey on drug use and health, United States, 2002–2014. Mmwr Surveill Summ 65(11):1–28

    Article  PubMed  Google Scholar 

  30. Ishida JH, Zhang AJ, Steigerwald S, Cohen BE, Vali M, Keyhani S (2020) Sources of information and beliefs about the health effects of marijuana. J Gen Intern Med 35(1):153–159. https://doi.org/10.1007/s11606-019-05335-6

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the National Institutes of Health/National Cancer Institute under award number R01 CA196337, K05 CA152715, P30 CA015704 and T32 CA094880. The authors would like to thank the generous study participants and research staff for their contributions.

Funding

PN was funded by R01 CA196337, K05 CA152715, and P30 CA015704.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. A. Newcomb.

Ethics declarations

Conflict of interest

The authors declare no potential conflicts of interest.

Ethical approval

This study was conducted in accordance with the ethical standards of the institutional review board at the Fred Hutchinson Cancer Research Center and with the 1964 Helsinki declaration and its later amendments.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PNG 67 KB)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Newcomb, P.A., Ton, M., Malen, R.C. et al. Cannabis use is associated with patient and clinical factors in a population-based sample of colorectal cancer survivors. Cancer Causes Control 32, 1321–1327 (2021). https://doi.org/10.1007/s10552-021-01468-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-021-01468-4

Keywords

  • Marijuana
  • Cannabis
  • Colorectal cancer
  • Survivorship
  • Epidemiology